慢性肾脏病对严重肢体缺血患者下肢旁路转流术结局的影响
基于美国外科质量改进计划数据库2012至2015年6978例因严重肢体缺血行下肢旁路转流术的患者,按慢性肾脏病分期分为轻中度、重度及血液透析三组,多变量分析显示重度慢性肾脏病与移植血管失效、术后心肌梗死和再入院相关,血液透析与术后心肌梗死、再入院及死亡率增加相关。
要点
- 重度慢性肾脏病与移植血管失效独立相关(OR 1.67,95%CI 1.12-2.50,P=0.01)。
- 血液透析患者术后心肌梗死、再入院及死亡率均增加。
- 重度慢性肾脏病患者术后并发症更差但死亡率未增加。
核心结论
- 慢性肾脏病是下肢旁路转流术后围手术期并发症的重要预测因素。
- 重度慢性肾脏病患者术后结局更差但死亡率未增加,血液透析患者生存率和术后结局更差。
研究设计与样本
- 回顾性队列研究,查询美国外科质量改进计划数据库2012至2015年因严重肢体缺血行下肢旁路转流术的患者,共6978例。
- 按慢性肾脏病分期分为三组:3期或以下(轻中度)6101例(87.4%)、4或5期(重度)327例(4.7%)、血液透析550例(7.9%)。
主要发现
- 重度慢性肾脏病组和血液透析组因组织缺损行血运重建的比例分别为68.8%和74.7%,高于轻中度组的54.9%(P<0.01)。
- 重度慢性肾脏病组和血液透析组早期移植血管失效、术后心肌梗死和再手术率更高。
- 多变量分析显示重度慢性肾脏病与移植血管失效(OR 1.67,95%CI 1.12-2.50,P=0.01)、术后心肌梗死(OR 2.16,95%CI 1.35-3.45,P<0.01)和再入院(OR 1.38,95%CI 1.06-1.80,P=0.02)相关。
- 血液透析与术后心肌梗死、再入院及死亡率增加相关。
- 其他与移植血管失效相关的因素包括功能状态(OR 1.39,95%CI 1.08-1.80,P=0.01)、非裔美国人种族(OR 1.72,95%CI 1.39-2.13,P<0.01)和远端旁路(OR 1.33,95%CI 1.09-1.61,P<0.01)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patient selection for open lower extremity revascularization in patients with chronic kidney disease (CKD) remains a clinical challenge. This study investigates the impact of CKD on early graft failure, postoperative complications, and mortality in patients undergoing lower extremity bypass for critical limb ischemia. METHODS: The National Surgical Quality Improvement Program database was queried for all patients with critical limb ischemia from 2012 to 2015 who underwent lower extremity bypass using the targeted vascular set. The glomerular filtration rate was calculated using the Chronic Kidney Disease Epidemiology Collaboration Study equation. CKD categories were determined from the National Kidney Foundation Kidney Disease Outcomes Quality Initiative staging criteria. Patients were classified into three groups: CKD stages 3 or lower (mild to moderate CKD), CKD stages 4 or 5 (severe CKD), and on hemodialysis (HD). Multiple variable analysis was used to examine graft failure, mortality, and postoperative complications. RESULTS: The Surgical Quality Improvement Program database identified 6978 patients who underwent infrainguinal lower extremity arterial bypass during the study period. There were 6101 patients (87.4%) with mild to moderate CKD, 327 (4.7%) with severe CKD, and 550 (7.9%) on HD. Patients with severe CKD and on HD were more likely to have revascularization for tissue loss (54.9% vs 68.8% and 74.7%; P < .01). Patients with severe CKD and those on HD had higher rates of early graft failure, postoperative myocardial infarction, and rates of reoperation. Multiple variable analysis confirmed these results showing that HD was associated with postoperative myocardial infarction, readmission, and increased mortality. It also demonstrated that severe CKD was associated with graft failure (odds ratio [OR], 1.67; 95% confidence interval [CI], 1.12-2.50; P = .01), postoperative myocardial infarction (OR, 2.16; 95% CI, 1.35-3.45; P < .01), and readmission (OR, 1.38; 95% CI, 1.06-1.80; P = .02). Other factors associated with graft failure include functional status (OR, 1.39; 95% CI, 1.08-1.80; P = .01), African American race (OR, 1.72; 95% CI, 1.39-2.13; P < .01), and distal bypass (OR, 1.33; 95% CI, 1.09-1.61; P < .01). CONCLUSIONS: CKD is a significant predictor of perioperative morbidity after lower extremity bypass. Patients with severe CKD have worse postoperative outcomes without increased mortality. Those on HD have worse survival and postoperative outcomes.
引用
- Ambur V, Park P, Gaughan JP, et al. The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia. J Vasc Surg. 2018. PMID: 30154013. doi:10.1016/j.jvs.2018.05.229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。